| アブストラクト | Using data from Vaccine Adverse Event Reporting System, we identified 69 reports of Guillain-Barre Syndrome (GBS) after Gardasil vaccination that occurred in the United States between 2006 and 2009. The onset of symptoms was within 6 weeks after vaccination in 70% of the patients in whom the date of vaccination was known. The estimated weekly reporting rate of post-Gardasil GBS within the first 6 weeks (6.6 per 10,000,000) was higher than that of the general population, and higher than post-Menactra and post-influenza vaccinations. Further prospective active surveillance for accurate ascertainment and identification of high-risk groups of GBS after Gardasil vaccination is warranted. |
|---|
| 投稿日 | 2010/09/28 |
|---|
| 投稿者 | Souayah, Nizar; Michas-Martin, P A; Nasar, Abu; Krivitskaya, Nataliya; Yacoub, Hussam A; Khan, Hafiz; Qureshi, Adnan I |
|---|
| ジャーナル名 | Vaccine |
|---|
| 組織名 | Department of Neurology, University of Medicine and Dentistry of New Jersey,;Newark, NJ 07103, USA. souayani@umdnj.edu |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/20869467/ |
|---|
